| Pharmaceutical active ingredients: |
| Gliclazide |
| Available forms, composition and doses of Nordialex: |
| N / A |
| Nordialex medical category: |
| Human:Antidiabetic agentsSulfonylureas |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BB09 - Gliclazide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Norcain | Benzocaine | Unidentified Pharmaceutical Company |
| Norcaine | Benzocaine | Unidentified Pharmaceutical Company |
| Norcainum | Benzocaine | Unidentified Pharmaceutical Company |
| Norcept | Ethinyl Estradiol; Norethindrone | Unidentified Pharmaceutical Company |
| Norcholine | Deanol | Unidentified Pharmaceutical Company |
| Nordicol | Estradiol | Unidentified Pharmaceutical Company |
| Nordopan | Uracil Mustard | Unidentified Pharmaceutical Company |
| Nordotropin | Somatropin | Unidentified Pharmaceutical Company |
| Noreinefrina | Norepinephrine | Unidentified Pharmaceutical Company |
| Norenol | Norfenefrine | Unidentified Pharmaceutical Company |